Ahead of major UN AIDS meeting, new HIV investment model is proposed

June 02, 2011

It has been exactly 30 years since HIV/AIDS was identified, and 10 years since the UN General Assembly Special Session on HIV/AIDS convened. To review progress, world leaders and experts on HIV AIDS will take part in a high level UN meeting in New York from June 8-10.

Ahead of this meeting, in a Health Policy published Online First by The Lancet, a group of HIV experts propose a new investment model intended to support better management of national and international HIV/AIDS responses than exists with the present system. The new model proposes a paradigm shift in the way AIDS funding is approached, with a greater emphasis on priority setting and optimization of AIDS responses, a shift to community mobilization to deliver programmes and greater synergies between programme elements. Implementing the model would require 30 per cent more funding than currently available when expenditure would be projected to peak, in 2015. The Health Policy is by Dr Bernhard Schwartländer, Joint United Nations Programme on HIV/AIDS (UNAIDS) Geneva, Switzerland, and colleagues.

The authors say: "Substantial changes are needed to achieve a more targeted and strategic approach to investment in the response to the HIV/AIDS epidemic that will yield long-term dividends...We propose an investment framework to support management of national and international HIV/AIDS responses, encourage transparency in programme objectives and results, and enable decision makers and financiers to galvanise support for effective action."

They add that, until now, advocacy for resources has been done on the basis of a commodity approach that encouraged scaling up of numerous strategies in parallel, irrespective of their relative effects. But the authors propose a more targeted approach. Basic programme activities in the framework range in complexity and consisted of procurement, distribution, and marketing of male and female condoms; activities designed to prevent mother-to-child transmission; promotion of medical male circumcision; integration of activities addressing key populations, in particular sex workers, men who have sex with men, and harm reduction programmes for injecting drug users; behaviour change programmes that target reduction of the risk of HIV exposure through changing of people's behaviours and social norms; and antiretroviral therapy programmes.

The new framework also stresses the importance of so called 'critical enablers'. that fall into two categories, social enablers that make environments conducive for rational HIV/AIDS responses possible and programme enablers that create demand for and help improve the performance of key interventions. Social stigma, poor health literacy, and a punitive legal environment hinder implementation of basic HIV/AIDS programme activities and adversely affect programme priorities by stifling of adoption of evidence-based policies and best practices. Complementary 'critical enabler' strategies to increase the effect of basic programme activities are therefore crucial to the success of HIV/AIDS programmes.

The authors conclude: "The yearly cost of achievement of universal access to HIV prevention, treatment, care, and support by 2015 is estimated at no less than US$22 billion*. Implementation of the new investment framework would avert 12•2 million new HIV infections and 7•4 million deaths from AIDS between 2011 and 2020 compared with continuation of present approaches, and result in 29•4 million life-years gained. The framework is cost effective at $1060 per life-year gained, and the additional investment proposed would be largely offset from savings in treatment costs alone."

Dr Schwartländer** adds: "With a more focused upfront investment we could really turn the HIV epidemic around ... it's not a question of whether we pay now or later. It is rather a question of whether we pay now or forever."
-end-
Dr Bernhard Schwartländer, Joint United Nations Programme on HIV/AIDS (UNAIDS) Geneva, Switzerland. T) +41-22-791 4902 E) SchwartländerB@unaids.org

Lancet

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.